Other languages Biovica International AB

Equities

BIOVIC B

SE0008613731

Market Closed - Nasdaq Stockholm Other stock markets 08:59:38 26/04/2024 pm IST			5-day change	1st Jan Change
1.706 ^SEK	+6.36%		-22.81%	-33.88%

13/04	Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024.	CI
12/04	Biovica International AB Announces Divitum® Tka in Observational Trial	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biovica International AB Announces Divitum® Tka in Observational Trial	12/04
Biovica International AB Announces Appointments to the Nomination Committee	11/04
Biovica International AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	14/03
Biovica Announces Interventional DiviTum TKa Trial Launches at Washington University	13/03
Biovica International Signs SEK 1.2 Million Master Service Agreement	12/03
Biovica Signs Master Service Agreement for Tka Testing with Leading Pharma Company	07/03
Biovica Partners with Palex Group to Launch Breast Cancer Treatment Response Kits; Stock Surges	19/01
Biovica International Signs Agreement with Palex Group	19/01
Biovica Receives License for Maryland State	01/12
Biovica International AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	28/11
Biovica Receives Final Pricing Decision for DiviTum TKa Test by Medicare	21/11
Biovica Signs Commercial Partner Agreement for the Divitum(R) Tka Assay in the Nordics with Axlab	13/11
Biovica International AB Signs Agreement for DivTum(R) TKa with World Re-Known Cancer Clinic	12/23/12
Biovica Signs Second Agreement with US Healthcare Provider	25/23/25
Biovica Signs US Agreement with Leading Healthcare Provider in Arizona	19/23/19
Biovica International AB Reports Earnings Results for the First Quarter Ended July 31, 2023	06/23/06
Biovica Announces the Start of a DiviTum(R) TKa Clinical Trial	24/23/24
Biovica Signs US Commercial Agreement with Occum Health	31/23/31
Biovica International Achieves PLA code for Medicare	21/23/21
Biovica International AB Reports Earnings Results for the Full Year Ended April 30, 2023	21/23/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biovica International AB

Equities

BIOVIC B

SE0008613731

Other languages

Filters